Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2103)
All Articles published online
|
Oct 15, 1999 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cui HF, Jiang XL. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol 1999; 5(5): 448-450 [PMID: 11819488 DOI: 10.3748/wjg.v5.i5.448] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i5/448.htm |
| Number | Citing Articles |
| 1 |
Liwen Hong, Gaoxian Chen, Zhengwei Cai, Hua Liu, Chen Zhang, Fei Wang, Zeyu Xiao, Jie Zhong, Lei Wang, Zhengting Wang, Wenguo Cui. Balancing Microthrombosis and Inflammation via Injectable Protein Hydrogel for Inflammatory Bowel Disease. Advanced Science 2022; 9(20) doi: 10.1002/advs.202200281
|
| 2 |
Valter Alvarenga, Rodrigo Goulart Pacheco, Christiano Costa Esposito, Fernanda Buongusto, Morgana Teixeira Lima Castelo-Branco, Kalil Madi, Celso R. Belmiro, Mauro Sergio Gonçalves Pavão, Heitor Siffert Pereira de Souza, Alberto Schanaider. Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitis. Surgery 2014; 155(2): 217 doi: 10.1016/j.surg.2013.06.057
|
| 3 |
Jun-Yong Luo, Yan Zhong, Ji-Chao Cao, Hui-Fei Cui. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis. Biomedicine & Pharmacotherapy 2011; 65(2): 111 doi: 10.1016/j.biopha.2010.12.013
|
| 4 |
Sheng-Li Ji, Hui-Fei Cui, Feng Shi, Yan-Qing Chi, Ji-Chao Cao, Mei-Yu Geng, Hua-Shi Guan. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes. World Journal of Gastroenterology 2004; 10(23): 3490-3494 doi: 10.3748/wjg.v10.i23.3490
|
| 5 |
Li Liu, Zhi-Peng Wang, Chang-Tai Xu, Bo-Rong Pan, Qi-Bing Mei, Yin Long, Jia-Yun Liu, Si-Yuan Zhou. Effects of <italic>Rheum tanguticum</italic> polysaccharide on TNBS -induced colitis and CD4<sup>+</sup> T cells in rats. World Journal of Gastroenterology 2003; 9(10): 2284-2288 doi: 10.3748/wjg.v9.i10.2284
|
| 6 |
Timothy J. Poterucha, Peter Libby, Samuel Z. Goldhaber. More than an anticoagulant: Do heparins have direct anti-inflammatory effects?. Thrombosis and Haemostasis 2017; 117(03): 437 doi: 10.1160/TH16-08-0620
|
| 7 |
Nilesh Chande, John WD McDonald, John K MacDonald, Nilesh Chande. Cochrane Database of Systematic Reviews. 2008; doi: 10.1002/14651858.CD006774.pub2
|
| 8 |
Xue-Liang Jiang, Hui-Fei Cui. An analysis of 10218 ulcerative colitis cases in China. World Journal of Gastroenterology 2002; 8(1): 158-161 doi: 10.3748/wjg.v8.i1.158
|
| 9 |
Xue-Liang Jiang, Hui-Fei Cui. Different therapy for different types of ulcerative colitis in China. World Journal of Gastroenterology 2004; 10(10): 1513-1520 doi: 10.3748/wjg.v10.i10.1513
|
| 10 |
L. PASTORELLI, S. SAIBENI, L. SPINA, C. SIGNORELLI, G. CELASCO, R. DE FRANCHIS, M. VECCHI. Oral, colonic‐release low‐molecular‐weight heparin: an initial open study of Parnaparin‐MMX for the treatment of mild‐to‐moderate left‐sided ulcerative colitis. Alimentary Pharmacology & Therapeutics 2008; 28(5): 581 doi: 10.1111/j.1365-2036.2008.03757.x
|
| 11 |
Nusrat A. Motlekar, Bi-Botti C. Youan. The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins. Journal of Controlled Release 2006; 113(2): 91 doi: 10.1016/j.jconrel.2006.04.008
|
| 12 |
G. CELASCO, A. PAPA, R. JONES, L. MORO, R. BOZZELLA, M. M. SURACE, G. C. NACCARI, G. GASBARRINI. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX®) for active left‐sided ulcerative colitis. Alimentary Pharmacology & Therapeutics 2010; 31(3): 375 doi: 10.1111/j.1365-2036.2009.04194.x
|
| 13 |
J. SHEN, Z. H. RAN, J. L. TONG, S. D. XIAO. Meta‐analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Alimentary Pharmacology & Therapeutics 2007; 26(5): 653 doi: 10.1111/j.1365-2036.2007.03418.x
|
| 14 |
Justin C Chang, Russell D Cohen. Medical management of severe ulcerative colitis. Gastroenterology Clinics of North America 2004; 33(2): 235 doi: 10.1016/j.gtc.2004.02.005
|
| 15 |
Giuseppe Celasco, Luigi Moro, Roberta Bozzella, Katia Mangano, Cinzia Quattrocchi, Caterina Aiello, Marco Donia, Paolo Fagone, Roberto Di Marco. Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat. Digestive Diseases and Sciences 2008; 53(12): 3170 doi: 10.1007/s10620-008-0299-6
|
| 16 |
Nilesh Chande, Yongjun Wang, John WD McDonald, John K MacDonald. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD006774.pub4
|
| 17 |
Wei-Guo Dong, Shao-Ping Liu, Hai-Hang Zhu, He-Sheng Luo, Jie-Ping Yu. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis. World Journal of Gastroenterology 2004; 10(4): 606-609 doi: 10.3748/wjg.v10.i4.606
|
| 18 |
Hu Zhang, Qin Ouyang, Zhong-Hui Wen, Claudio Fiocchi, Wei-Ping Liu, Dai-Yun Chen, Feng-Yuan Li. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World Journal of Gastroenterology 2005; 11(12): 1775-1778 doi: 10.3748/wjg.v11.i12.1775
|
| 19 |
Gang Xu, Ke-Li Tian, Guo-Ping Liu, Xue-Jun Zhong, Shao-Ling Tang, Yan-Ping Sun. Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis. World Journal of Gastroenterology 2002; 8(3): 575-576 doi: 10.3748/wjg.v8.i3.575
|
| 20 |
Nilesh Chande, John K. MacDonald, Josh J. Wang, John W.D. McDonald. Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials. Inflammatory Bowel Diseases 2011; 17(9): 1979 doi: 10.1002/ibd.21776
|
| 21 |
Yvette Meissner, Nathalie Ubrich, Fatima El Ghazouani, Philippe Maincent, Alf Lamprecht. Low molecular weight heparin loaded pH-sensitive microparticles. International Journal of Pharmaceutics 2007; 335(1-2): 147 doi: 10.1016/j.ijpharm.2006.11.014
|
| 22 |
Naamah L. Zitomersky, Menno Verhave, Cameron C. Trenor. Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention. Inflammatory Bowel Diseases 2011; 17(1): 458 doi: 10.1002/ibd.21334
|
| 23 |
Qi Ying Lean, Nuri Gueven, Rajaraman D Eri, Rajesh Bhatia, Sukhwinder Singh Sohal, Niall Stewart, Gregory M Peterson, Rahul P Patel. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes. Expert Review of Clinical Pharmacology 2015; 8(6): 795 doi: 10.1586/17512433.2015.1082425
|
| 24 |
Marija Veljača. Pharmacotherapy of Gastrointestinal Inflammation. 2004; : 17 doi: 10.1007/978-3-0348-7930-9_2
|
| 25 |
Nilesh Chande, John WD McDonald, John K MacDonald, Josh J Wang, Nilesh Chande. Cochrane Database of Systematic Reviews. 2010; doi: 10.1002/14651858.CD006774.pub3
|
| 26 |
Junyong Luo, Jichao Cao, Xueliang Jiang, Huifei Cui. Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice. Biomedicine & Pharmacotherapy 2010; 64(7): 441 doi: 10.1016/j.biopha.2010.01.013
|